Polypid earnings were -$34.5M for the trailing 12 months ending Jun 30, 2025, with -66.7% growth year over year. The latest PYPD earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$10.0M, up 20.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PYPD reported annual earnings of -$29.0M, with 21.6% growth.
PYPD past earnings growth
How has PYPD's earnings growth performed historically?
On PYPD's earnings call on Invalid Date, Polypid (NASDAQ: PYPD) reported Q2 2025 earnings per share (EPS) of $0.78, up 37.6% year over year. Total PYPD earnings for the quarter were -$9.98 million. In the same quarter last year, Polypid's earnings per share (EPS) was $1.25.
As of the last Polypid earnings report, Polypid is currently losing money. Polypid's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$34.53 million, a 39.77% increase year over year.
What was PYPD's earnings growth in the past year?
As of Polypid's earnings date in Invalid Date, Polypid's earnings has grown -66.7% year over year. This is 97.9 percentage points lower than the US Biotechnology industry earnings growth rate of 31.19%. PYPD earnings in the past year totalled -$34.53 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.